Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Sep 6;21(9):1091-1092.
doi: 10.1093/neuonc/noz115.

HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma

Oren J Becher  1   2   3
Affiliations
Editorial

HDAC inhibitors to the rescue in sonic hedgehog medulloblastoma

Oren J Becher. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
HDAC inhibitors as novel SMO-independent SHH pathway inhibitors.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Kool M, Korshunov A, Remke M, et al. . Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012;123(4):473–484. - PMC - PubMed
    1. Taipale J, Chen JK, Cooper MK, et al. . Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature. 2000;406(6799):1005–1009. - PubMed
    1. Kool M, Jones DT, Jäger N, et al. ; ICGC PedBrain Tumor Project Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 2014;25(3):393–405. - PMC - PubMed
    1. Yauch RL, Dijkgraaf GJ, Alicke B, et al. . Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science. 2009;326(5952):572–574. - PMC - PubMed
    1. Robinson GW, Kaste SC, Chemaitilly W, et al. . Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor. Oncotarget. 2017;8(41):69295–69302. - PMC - PubMed

MeSH terms